Evidence map›Paper›PMID 32963793›Full record

ArticleCanadian journal of kidney health and disease2020

Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study.

Karthik K Tennankore, Lakshman Gunaratnam, Rita S Suri, Seychelle Yohanna, Michael Walsh, Navdeep Tangri, Bhanu Prasad, Nessa Gogan, Kenneth Rockwood, Steve Doucette and 5 more

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Old Age and Frailty in Deceased Organ Transplantation and Allocation-A Plea for Geriatric Assessment and Prehabilitation.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Karthik K TennankoreDivision of Nephrology, Department of Medicine, Dalhousie University & Nova Scotia Health Authority, Halifax, Canada.ORCID https://orcid.org/0000-0002-7919-6709
Lakshman GunaratnamDivision of Nephrology, Department of Medicine, Western University, London, ON, Canada.
Rita S SuriDivision of Nephrology and Research Institute, Department of Medicine, McGill University/Centre de Recherche de l'Université de Montréal, QC, Canada.ORCID https://orcid.org/0000-0002-0519-3927
Seychelle YohannaDepartment of Medicine, McMaster University, Hamilton, ON, Canada.
Michael WalshDepartments of Medicine and Health Research Methods, Evidence & Impact, McMaster University, Hamilton, ON, Canada.
Navdeep TangriDepartment of Medicine and Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
Bhanu PrasadRegina General Hospital, SK, Canada.ORCID https://orcid.org/0000-0002-1139-4821
Nessa GoganDivision of Nephrology, Department of Medicine, Horizon Health Network, Dalhousie University, Saint John, NB, Canada.
Kenneth RockwoodDivision of Geriatric Medicine, Department of Medicine, Department of Community Health and Epidemiology, School of Health Administration, Halifax, NS, Canada.
Steve DoucetteResearch Methods Unit, Nova Scotia Health Authority, Halifax, Canada.
Laura SillsMulti-Organ Transplant Program, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Bryce KiberdDalhousie University, Halifax, NS, Canada.
Tammy Keough-RyanDivision of Nephrology, Department of Medicine, Dalhousie University & Nova Scotia Health Authority, Halifax, Canada.
Kenneth WestDivision of Nephrology, Department of Medicine, Dalhousie University & Nova Scotia Health Authority, Halifax, Canada.
Amanda VinsonDivision of Nephrology, Department of Medicine, Dalhousie University & Nova Scotia Health Authority, Halifax, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding how frailty affects patients listed for transplantation has been identified as a priority research need. Frailty may be associated with a high risk of death or wait-list withdrawal, but this has not been evaluated in a large multicenter cohort of Canadian wait-listed patients.

objectiveThe primary objective is to evaluate whether frailty is associated with death or permanent withdrawal from the transplant wait list. Secondary objectives include assessing whether frailty is associated with hospitalization, quality of life, and the probability of being accepted to the wait list.

designProspective cohort study.

settingSeven sites with established renal transplant programs that evaluate patients for the kidney transplant wait list. PATIENTS: Individuals who are being considered for the kidney transplant wait list. MEASUREMENTS: We will assess frailty using the Fried Phenotype, a frailty index, the Short Physical Performance Battery, and the Clinical Frailty Scale at the time of listing for transplantation. We will also assess frailty at the time of referral to the wait list and annually after listing in a subgroup of patients.

methodsThe primary outcome of the composite of time to death or permanent wait-list withdrawal will be compared between patients who are frail and those who are not frail and will account for the competing risks of deceased and live donor transplantation. Secondary outcomes will include number of hospitalizations and length of stay, and in a subset, changes in frailty severity over time, change in quality of life, and the probability of being listed. Recruitment of 1165 patients will provide >80% power to identify a relative hazard of ≥1.7 comparing patients who are frail to those who are not frail for the primary outcome (2-sided α = .05), whereas a more conservative recruitment target of 624 patients will provide >80% power to identify a relative hazard of ≥2.0.

resultsThrough December 2019, 665 assessments of frailty (inclusive of those for the primary outcome and all secondary outcomes including repeated measures) have been completed. LIMITATIONS: There may be variation across sites in the processes of referral and listing for transplantation that will require consideration in the analysis and results.

conclusionsThis study will provide a detailed understanding of the association between frailty and outcomes for wait-listed patients. Understanding this association is necessary before routinely measuring frailty as part of the wait-list eligibility assessment and prior to ascertaining the need for interventions that may modify frailty.

trial registrationNot applicable as this is a protocol for a prospective observational study.

Indexed as

cohort studydialysisfrailtytransplanttransplantationwait list

Identifiers

PMID32963793
PMCPMC7488612

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.